Anna Junker

15PUBLICATIONS
34CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and designBiologically active moleculesCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 16, 2026
Fluorine-18-Labeled Nucleotide Analogs Targeting Ecto-5'-Nucleotidase (CD73) for Positron Emission Tomography Imaging of Solid Tumors.

Clemens Dobelmann, Constanze C Schmies, Georg Wilhelm Rolshoven

|Feb 26, 2026
5'-Ectonucleotidase (CD73) inhibitors: a patent review (2021-present).

Zhaolin Wang, Anna Junker

|Jan 13, 2025
Naphtho[1,2-b][1,4]diazepinedione-Based P2X4 Receptor Antagonists from Structure-Activity Relationship Studies toward PET Tracer Development.

Katharina Sophie Erlitz, Ann-Kathrin Prinz, Stefan Wagner

|Dec 31, 2024
Piperazine-based P2X4 receptor antagonists.

Katharina Sophie Erlitz, Alena I Siutkina, Ann-Kathrin Prinz

|Nov 24, 2024
Phenol (bio)isosteres in drug design and development.

Calvin Dunker, Katja Schlegel, Anna Junker

|Nov 01, 2024
Discovery of Anthranilic Acid Derivatives as Antagonists of the Pro-Inflammatory Orphan G Protein-Coupled Receptor GPR17.

Nader M Boshta, Michael Lewash, Meryem Köse

Pageof 3